As canonical Wnt or TGF-β/BMP signaling pathways were downregulated in melanoma and, when activated, enhanced melanocyte regeneration, we next aimed to test whether activation of either pathway exerts anti-cancer effects on the SK-MEL-28, a human malignant melanoma cell line. The gene discussed is TGFB1; the disease is melanoma.